<?xml version="1.0" encoding="UTF-8"?>
<p id="Par146">On 1 February 2016, the WHO declared PHEIC amid concerns that the outbreak of Zika virus occurring across the Caribbean and Latin America was linked to cases of congenital microcephaly and Guillain-Barré syndrome.
 <xref ref-type="fn" rid="Fn102">102</xref> Just days later, news reporting indicated that Brazil, then “the epicenter of the ongoing Zika crisis” was not sharing vital epidemiological information or virus samples with the international public health community.
 <xref ref-type="fn" rid="Fn103">103</xref> In 2015, the Brazilian government introduced new legislation regulating access to the country’s genetic resources. Brazil’s Biodiversity Law (Law No. 13,123), legislation implementing the CBD,
 <xref ref-type="fn" rid="Fn104">104</xref> had only become effective on 17 November 2015 so there was still a great deal of confusion as to how to go about accessing and sharing genetic resources (including microorganisms) from Brazil.
 <xref ref-type="fn" rid="Fn105">105</xref> One news report quoted the president of a state-run research institute as saying “[u]ntil the law is implemented, we’re legally prohibited from sending samples abroad. Even if we wanted to send this material abroad, we can’t because it’s considered a crime”.
 <xref ref-type="fn" rid="Fn106">106</xref> This rankled U.S. and European scientists who were forced “to work with samples from previous outbreaks” or obtain virus samples surreptitiously.
 <xref ref-type="fn" rid="Fn107">107</xref>
</p>
